Brind.

VolitionRx filed a registration statement with the Securities and Exchange Commission on August 5, 2025.

2 reports, 1 independent Updated Aug 5
Gone quiet
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

VolitionRx filed a registration statement with the Securities and Exchange Commission on August 5, 2025.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. UK company VolitionRx filed a registration statement with the SEC.1 source
  2. VolitionRx utilizes the Nu.Q® Discover platform for profiling services.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • PR NewswireVolitionRx Announces Pricing of $1.2 Million Registered Direct Offering HENDERSON, Nev., Aug. 4, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE American: VNRX) ("Volition" or the "Company"), a multi-n
  • PR NewswireNu.Q® Discover Expands Global Adoption and Epigenetic Innovation HENDERSON, Nev., July 16, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics com